These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 19833757

  • 21. Definition and treatment of lupus flares measured by the BILAG index.
    Gordon C, Sutcliffe N, Skan J, Stoll T, Isenberg DA.
    Rheumatology (Oxford); 2003 Nov; 42(11):1372-9. PubMed ID: 12810926
    [Abstract] [Full Text] [Related]

  • 22. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.
    Walz LeBlanc BA, Gladman DD, Urowitz MB.
    J Rheumatol; 1994 Dec; 21(12):2239-41. PubMed ID: 7699623
    [Abstract] [Full Text] [Related]

  • 23. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.
    Szeto CC, Mok HY, Chow KM, Lee TC, Leung JY, Li EK, Tsui TK, Yu S, Tam LS.
    J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942
    [Abstract] [Full Text] [Related]

  • 24. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [Abstract] [Full Text] [Related]

  • 25. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 26. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J.
    Arthritis Res Ther; 2015 Nov 25; 17():341. PubMed ID: 26608564
    [Abstract] [Full Text] [Related]

  • 27. Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.
    Narayanan K, Marwaha V, Shanmuganandan K, Shankar S.
    Med J Armed Forces India; 2010 Apr 25; 66(2):102-7. PubMed ID: 27365721
    [Abstract] [Full Text] [Related]

  • 28. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W.
    Arthritis Rheum; 2008 Aug 25; 58(8):2453-9. PubMed ID: 18668552
    [Abstract] [Full Text] [Related]

  • 29. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 25; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 30. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May 25; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 31. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.
    Barrera-Vargas A, Quintanar-Martínez M, Merayo-Chalico J, Alcocer-Varela J, Gómez-Martín D.
    Rheumatology (Oxford); 2016 Mar 25; 55(3):429-35. PubMed ID: 26396262
    [Abstract] [Full Text] [Related]

  • 32. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M, Balada E, Cortés F, Pérez EH, Vilardell-Tarrés M, Ordi-Ros J.
    J Rheumatol; 2009 May 25; 36(5):953-60. PubMed ID: 19332622
    [Abstract] [Full Text] [Related]

  • 33. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
    Ramos-Casals M, Font J, García-Carrasco M, Cervera R, Jiménez S, Trejo O, de la Red G, Sánchez-Tapias JM, Ingelmo M.
    Arthritis Rheum; 2000 Dec 25; 43(12):2801-6. PubMed ID: 11145039
    [Abstract] [Full Text] [Related]

  • 34. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 25; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.
    Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA.
    Rheumatology (Oxford); 2004 Aug 25; 43(8):1039-44. PubMed ID: 15161983
    [Abstract] [Full Text] [Related]

  • 36. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep 25; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 37. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
    Bruce IN, Hallett DC, Gladman DD, Urowitz MB.
    J Rheumatol; 1999 Jul 25; 26(7):1490-4. PubMed ID: 10405935
    [Abstract] [Full Text] [Related]

  • 38. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec 25; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 39. Seasonal variations of systemic lupus erythematosus flares in southern France.
    Chiche L, Jourde N, Ulmann C, Mancini J, Darque A, Bardin N, Dicostanzo MP, Thomas G, Harlé JR, Vienne J, Loukos H, Bornet C.
    Eur J Intern Med; 2012 Apr 25; 23(3):250-4. PubMed ID: 22385883
    [Abstract] [Full Text] [Related]

  • 40. Menopause hormonal therapy in women with systemic lupus erythematosus.
    Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Díaz J, Cravioto MD.
    Arthritis Rheum; 2007 Sep 25; 56(9):3070-9. PubMed ID: 17763408
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.